2024-518229-13-00
Active, not recruiting
Phase 1
A clinical study of MK-2828 in healthy people (MK-2828-002)
Merck Sharp & Dohme LLC1 site in 1 country40 target enrollmentStarted: December 20, 2024Last updated:
Overview
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 40
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Kiki Cunningham-Bussel
Scientific
Merck Sharp & Dohme LLC
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A clinical study of MK-7228 in healthy men (MK-7228-001)2024-520214-22-00Merck Sharp & Dohme LLC24
Recruiting
Not Applicable
Phase I Clinical Trial of KK2845 in Patients with Relapsed or Refractory Acute Myeloid LeukemiajRCT2011240008Kyowa Kirin Co., Ltd.48
Completed
Not Applicable
Single and Multiple Dose Study of MK-4482 in Healthy Japanese AdultsjRCT2031210010MSD K.K.72
Completed
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-002)2024-516899-15-00Merck Sharp & Dohme LLC40
Completed
Phase 1
A clinical study of MK-2420 in healthy men (MK-2420-003)2024-518104-47-00Merck Sharp & Dohme LLC48